Literature DB >> 7594715

Mycobacterium tuberculosis is strikingly more virulent for mice when given via the respiratory than via the intravenous route.

R J North1.   

Abstract

Fewer Mycobacterium tuberculosis colony-forming units given by aerosol were substantially more virulent for mice than much larger numbers inoculated intravenously (iv), as shown by a faster rate of bacillary growth in the lungs and much shorter survival of the host. Earlier death of mice infected by aerosol was associated with faster development of lung pathology, even though the number of M. tuberculosis given iv resulted in the same number of bacilli initially implanting in the lungs as the number given by aerosol. Mice depleted of CD4 T cells died of infection much sooner than immunocompetent mice but at about the same time after being infected via either route. The results indicate that a small number of M. tuberculosis colony-forming units given by aerosol is less immunogenic than a larger number given iv.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7594715     DOI: 10.1093/infdis/172.6.1550

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

1.  Latency-associated peptide of transforming growth factor beta enhances mycobacteriocidal immunity in the lung during Mycobacterium bovis BCG infection in C57BL/6 mice.

Authors:  K A Wilkinson; T D Martin; S M Reba; H Aung; R W Redline; W H Boom; Z Toossi; S A Fulton
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

2.  Sequestration of Mycobacterium tuberculosis in tight vacuoles in vivo in lung macrophages of mice infected by the respiratory route.

Authors:  A L Moreira; J Wang; L Tsenova-Berkova; W Hellmann; V H Freedman; G Kaplan
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

3.  Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis.

Authors:  Therese Vallerskog; Gregory W Martens; Hardy Kornfeld
Journal:  J Immunol       Date:  2010-04-26       Impact factor: 5.422

4.  Vaccinated mice remain more susceptible to Mycobacterium tuberculosis infection initiated via the respiratory route than via the intravenous route.

Authors:  R J North; R LaCourse; L Ryan
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

5.  Classification and reporting of severity experienced by animals used in scientific procedures: FELASA/ECLAM/ESLAV Working Group report.

Authors:  David Smith; David Anderson; Anne-Dominique Degryse; Carla Bol; Ana Criado; Alessia Ferrara; Nuno Henrique Franco; Istvan Gyertyan; Jose M Orellana; Grete Ostergaard; Orsolya Varga; Hanna-Marja Voipio
Journal:  Lab Anim       Date:  2018-02       Impact factor: 2.471

6.  Infection of mice with aerosolized Mycobacterium tuberculosis: use of a nose-only apparatus for delivery of low doses of inocula and design of an ultrasafe facility.

Authors:  J Reid Schwebach; Bing Chen; Aharona Glatman-Freedman; Arturo Casadevall; John D McKinney; John L Harb; Patrick J McGuire; W Emmett Barkley; Barry R Bloom; William R Jacobs
Journal:  Appl Environ Microbiol       Date:  2002-09       Impact factor: 4.792

7.  Mycobacterium tuberculosis H37Rv: Delta RD1 is more virulent than M. bovis bacille Calmette-Guérin in long-term murine infection.

Authors:  David R Sherman; Kristi M Guinn; Mark J Hickey; Sanjeev K Mathur; Kelly L Zakel; Sherilyn Smith
Journal:  J Infect Dis       Date:  2004-06-11       Impact factor: 5.226

8.  'Immunization' against airborne tuberculosis by an earlier primary response to a concurrent intravenous infection.

Authors:  Yu-Jin Jung; Ronald LaCourse; Lynn Ryan; Robert J North
Journal:  Immunology       Date:  2008-01-23       Impact factor: 7.397

9.  Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype.

Authors:  E Medina; R J North
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

10.  Protection by CD4 or CD8 T cells against pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection.

Authors:  Z Xing; J Wang; K Croitoru; J Wakeham
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.